• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对乙酰氨基酚诱导的肝损伤研究进展

Advances in the study of acetaminophen-induced liver injury.

作者信息

Li Xinghui, Ni Jiaqi, Chen Li

机构信息

West China School of Pharmacy, Sichuan University, Chengdu, China.

Department of Pharmacy, Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University, Chengdu, China.

出版信息

Front Pharmacol. 2023 Aug 4;14:1239395. doi: 10.3389/fphar.2023.1239395. eCollection 2023.

DOI:10.3389/fphar.2023.1239395
PMID:37601069
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10436315/
Abstract

Acetaminophen (APAP) overdose is a significant cause of drug-induced liver injury and acute liver failure. The diagnosis, screening, and management of APAP-induced liver injury (AILI) is challenging because of the complex mechanisms involved. Starting from the current studies on the mechanisms of AILI, this review focuses on novel findings in the field of diagnosis, screening, and management of AILI. It highlights the current issues that need to be addressed. This review is supposed to summarize the recent research progress and make recommendations for future research.

摘要

对乙酰氨基酚(APAP)过量是药物性肝损伤和急性肝衰竭的重要原因。由于涉及的机制复杂,APAP诱导的肝损伤(AILI)的诊断、筛查和管理具有挑战性。从目前关于AILI机制的研究出发,本综述重点关注AILI诊断、筛查和管理领域的新发现。它突出了当前需要解决的问题。本综述旨在总结近期的研究进展并为未来研究提出建议。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81a3/10436315/9f99de35f492/fphar-14-1239395-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81a3/10436315/58d2b389e1d1/fphar-14-1239395-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81a3/10436315/310d4870db08/fphar-14-1239395-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81a3/10436315/225c0c005a32/fphar-14-1239395-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81a3/10436315/da6b30ed25fb/fphar-14-1239395-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81a3/10436315/2120d23b309d/fphar-14-1239395-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81a3/10436315/9f99de35f492/fphar-14-1239395-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81a3/10436315/58d2b389e1d1/fphar-14-1239395-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81a3/10436315/310d4870db08/fphar-14-1239395-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81a3/10436315/225c0c005a32/fphar-14-1239395-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81a3/10436315/da6b30ed25fb/fphar-14-1239395-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81a3/10436315/2120d23b309d/fphar-14-1239395-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81a3/10436315/9f99de35f492/fphar-14-1239395-g006.jpg

相似文献

1
Advances in the study of acetaminophen-induced liver injury.对乙酰氨基酚诱导的肝损伤研究进展
Front Pharmacol. 2023 Aug 4;14:1239395. doi: 10.3389/fphar.2023.1239395. eCollection 2023.
2
Cathelicidin promotes liver repair after acetaminophen-induced liver injury in mice.在小鼠中,杀菌肽促进对乙酰氨基酚诱导的肝损伤后的肝脏修复。
JHEP Rep. 2023 Jan 31;5(4):100687. doi: 10.1016/j.jhepr.2023.100687. eCollection 2023 Apr.
3
Molecular pathogenesis of acetaminophen-induced liver injury and its treatment options.对乙酰氨基酚诱导的肝损伤的分子发病机制及其治疗选择。
J Zhejiang Univ Sci B. 2022 Apr 15;23(4):265-285. doi: 10.1631/jzus.B2100977.
4
Galangin Prevents Acute Hepatorenal Toxicity in Novel Propacetamol-Induced Acetaminophen-Overdosed Mice.高良姜预防新型丙帕他莫诱导的对乙酰氨基酚过量小鼠的急性肝肾毒性。
J Med Food. 2015 Nov;18(11):1187-97. doi: 10.1089/jmf.2014.3328. Epub 2015 Jun 4.
5
Role of caspase-8 and/or -9 as biomarkers that can distinguish the potential to cause toxic- and immune related-adverse event, for the progress of acetaminophen-induced liver injury.半胱天冬氨酸蛋白酶-8 和/或 -9 作为生物标志物在区分潜在的毒性和免疫相关不良事件中的作用,用于进展性对乙酰氨基酚诱导的肝损伤。
Life Sci. 2022 Apr 1;294:120351. doi: 10.1016/j.lfs.2022.120351. Epub 2022 Jan 29.
6
Growth differentiation factor 15 is dispensable for acetaminophen-induced liver injury in mice.生长分化因子15对小鼠对乙酰氨基酚诱导的肝损伤并非必需。
Basic Clin Pharmacol Toxicol. 2023 Apr;132(4):343-353. doi: 10.1111/bcpt.13834. Epub 2023 Jan 11.
7
Inhibition of BTK improved APAP-induced liver injury via suppressing proinflammatory macrophages activation by restoring mitochondrion function.通过恢复线粒体功能抑制促炎巨噬细胞激活,抑制 BTK 可改善对乙酰氨基酚诱导的肝损伤。
Int Immunopharmacol. 2022 Sep;110:109036. doi: 10.1016/j.intimp.2022.109036. Epub 2022 Jul 15.
8
Decreased plasma acetaminophen glucuronide/acetaminophen concentration ratio warns the onset of acetaminophen-induced liver injury.血浆对乙酰氨基酚葡萄糖醛酸苷/对乙酰氨基酚浓度比值降低预示着对乙酰氨基酚诱导的肝损伤的发生。
Biopharm Drug Dispos. 2022 Jun;43(3):108-116. doi: 10.1002/bdd.2316. Epub 2022 May 17.
9
Syndecan-1 limits the progression of liver injury and promotes liver repair in acetaminophen-induced liver injury in mice.Syndecan-1可限制小鼠对乙酰氨基酚诱导的肝损伤的进展,并促进肝脏修复。
Hepatology. 2017 Nov;66(5):1601-1615. doi: 10.1002/hep.29265. Epub 2017 Sep 26.
10
Targeting innate immune responses to attenuate acetaminophen-induced hepatotoxicity.针对先天性免疫反应以减轻对乙酰氨基酚诱导的肝毒性。
Biochem Pharmacol. 2022 Aug;202:115142. doi: 10.1016/j.bcp.2022.115142. Epub 2022 Jun 11.

引用本文的文献

1
Advancing hepatotoxicity assessment: current advances and future directions.推进肝毒性评估:当前进展与未来方向
Toxicol Res. 2025 Apr 24;41(4):303-323. doi: 10.1007/s43188-025-00289-w. eCollection 2025 Jul.
2
Sakuranetin Prevents Acetaminophen-Induced Liver Injury via Nrf2-Induced Inhibition of Hepatocyte Ferroptosis.樱花素通过Nrf2诱导的对肝细胞铁死亡的抑制作用预防对乙酰氨基酚诱导的肝损伤。
Drug Des Devel Ther. 2025 Jan 10;19:159-171. doi: 10.2147/DDDT.S497817. eCollection 2025.
3
Efficacy of postoperative analgesia with intravenous paracetamol and mannitol injection, combined with thoracic paravertebral nerve block in post video-assisted thoracoscopic surgery pain: a prospective, randomized, double-blind controlled trial.

本文引用的文献

1
Galactosylated hydroxyl-polyamidoamine dendrimer targets hepatocytes and improves therapeutic outcomes in a severe model of acetaminophen poisoning-induced liver failure.半乳糖基化羟基聚酰胺胺树枝状大分子靶向肝细胞并改善对乙酰氨基酚中毒诱导的肝衰竭严重模型的治疗效果。
Bioeng Transl Med. 2023 Feb 8;8(3):e10486. doi: 10.1002/btm2.10486. eCollection 2023 May.
2
The Role of Carbamoyl Phosphate Synthetase 1 as a Prognostic Biomarker in Patients With Acetaminophen-induced Acute Liver Failure.氨甲酰磷酸合成酶 1 在乙酰氨基酚诱导的急性肝衰竭患者中的预后生物标志物作用。
Clin Gastroenterol Hepatol. 2023 Nov;21(12):3060-3069.e8. doi: 10.1016/j.cgh.2023.03.002. Epub 2023 Mar 27.
3
静脉注射对乙酰氨基酚和甘露醇注射联合胸椎旁神经阻滞用于电视辅助胸腔镜手术后疼痛的疗效:一项前瞻性、随机、双盲对照试验。
BMC Anesthesiol. 2024 Jan 4;24(1):14. doi: 10.1186/s12871-023-02386-5.
Circulating Cell-Free DNAs as a Biomarker and Therapeutic Target for Acetaminophen-Induced Liver Injury.
循环细胞游离 DNA 作为乙酰氨基酚诱导肝损伤的生物标志物和治疗靶点。
Adv Sci (Weinh). 2023 Jun;10(16):e2206789. doi: 10.1002/advs.202206789. Epub 2023 Apr 10.
4
Role of HNF4alpha-cMyc interaction in liver regeneration and recovery after acetaminophen-induced acute liver injury.HNF4alpha-cMyc 相互作用在乙酰氨基酚诱导的急性肝损伤后肝脏再生和恢复中的作用。
Hepatology. 2023 Oct 1;78(4):1106-1117. doi: 10.1097/HEP.0000000000000367. Epub 2023 Apr 7.
5
Drug-induced liver injury: a comprehensive review.药物性肝损伤:综述
Therap Adv Gastroenterol. 2023 Mar 21;16:17562848231163410. doi: 10.1177/17562848231163410. eCollection 2023.
6
Tandem mass tag-based quantitative proteomic profiling identifies candidate serum biomarkers of drug-induced liver injury in humans.基于串联质量标签的定量蛋白质组学分析鉴定出人类药物性肝损伤的候选血清生物标志物。
Nat Commun. 2023 Mar 3;14(1):1215. doi: 10.1038/s41467-023-36858-6.
7
A human liver organoid screening platform for DILI risk prediction.用于 DILI 风险预测的人类肝类器官筛选平台。
J Hepatol. 2023 May;78(5):998-1006. doi: 10.1016/j.jhep.2023.01.019. Epub 2023 Feb 3.
8
Supervised chemical graph mining improves drug-induced liver injury prediction.监督式化学图谱挖掘可改善药物性肝损伤预测。
iScience. 2022 Dec 26;26(1):105677. doi: 10.1016/j.isci.2022.105677. eCollection 2023 Jan 20.
9
Scavenger receptor a is a major homeostatic regulator that restrains drug-induced liver injury.清道夫受体 A 是一种主要的内稳态调节剂,可抑制药物性肝损伤。
Hepatology. 2023 Jul 1;78(1):45-57. doi: 10.1097/HEP.0000000000000044. Epub 2023 Jan 13.
10
Hepatocyte-specific Mas activation enhances lipophagy and fatty acid oxidation to protect against acetaminophen-induced hepatotoxicity in mice.肝细胞特异性Mas激活增强脂质自噬和脂肪酸氧化,以保护小鼠免受对乙酰氨基酚诱导的肝毒性。
J Hepatol. 2023 Mar;78(3):543-557. doi: 10.1016/j.jhep.2022.10.028. Epub 2022 Nov 9.